PL376659A1 - Skondensowane związki heterocykliczne - Google Patents

Skondensowane związki heterocykliczne

Info

Publication number: PL376659A1
Authority: PL; Poland
Prior art keywords: heterocyclic compounds; fused heterocyclic; fused; compounds; heterocyclic
Prior art date: 2002-11-06

Application number

PL376659A

Other languages

English (en)

Inventor

Xi Chen

Xiaoqi Chen

Pingchen Fan

Juan Jaen

Leping Li

Jeffrey T. Mihalic

Original Assignee

Tularik Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-06

Filing date

2003-11-06

Publication date

2006-01-09

2003-11-06 Application filed by Tularik Inc. filed Critical Tularik Inc.

2006-01-09 Publication of PL376659A1 publication Critical patent/PL376659A1/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL376659A 2002-11-06 2003-11-06 Skondensowane związki heterocykliczne PL376659A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US42445602P	2002-11-06	2002-11-06

Publications (1)

Publication Number	Publication Date
PL376659A1 true PL376659A1 (pl)	2006-01-09

Family

ID=32312811

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL376659A PL376659A1 (pl)	2002-11-06	2003-11-06	Skondensowane związki heterocykliczne

Country Status (16)

Country	Link
US (2)	US7253179B2 (pl)
EP (1)	EP1562943A1 (pl)
JP (1)	JP4547266B2 (pl)
KR (1)	KR20050103184A (pl)
CN (2)	CN101134757A (pl)
AU (1)	AU2003285160B2 (pl)
BR (1)	BR0316070A (pl)
CA (1)	CA2505372A1 (pl)
EA (1)	EA009421B1 (pl)
IS (1)	IS7833A (pl)
MX (1)	MXPA05004739A (pl)
NO (1)	NO20052655L (pl)
NZ (1)	NZ540328A (pl)
PL (1)	PL376659A1 (pl)
WO (1)	WO2004043958A1 (pl)
ZA (1)	ZA200503654B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6809104B2 (en) *	2001-05-04	2004-10-26	Tularik Inc.	Fused heterocyclic compounds
US20070135425A1 (en) *	2001-05-04	2007-06-14	Amgen Inc.	Fused heterocyclic compounds
PL376659A1 (pl) *	2002-11-06	2006-01-09	Tularik Inc.	Skondensowane związki heterocykliczne
AU2004209505B2 (en)	2003-02-10	2009-07-23	Banyu Pharmaceutical Co., Ltd.	Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
DE102010025663A1 (de) *	2010-06-30	2012-01-05	Karl-Heinz Glüsenkamp	Neue beta-Aminoaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre chemische Verwendung als reaktive Intermediate
MX2013001612A (es) *	2010-08-10	2013-07-05	Abbvie Inc	Moduladores de trpv3 novedosos.
WO2012129491A1 (en)	2011-03-24	2012-09-27	Abbott Laboratories	Trpv3 modulators
CA2853097A1 (en) *	2011-10-24	2013-05-02	Abbvie Inc.	Novel trpv3 modulators
CN106588812B (zh) *	2016-12-07	2019-02-22	烟台大学	一种酰氯制备2，4-二取代噻唑啉类化合物的方法
HRP20250104T1 (hr)	2019-01-14	2025-03-28	Zydus Lifesciences Limited	Novi supstituirani derivati sulfonilureje
HUP2200222A1 (hu)	2022-06-17	2023-12-28	Richter Gedeon Nyrt	MCHR1 antagonisták a Prader-Willi szindróma kezelésére

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US199549A (en) *		1878-01-22		Improvement in screw-propellers
US23085A (en) *		1859-03-01		chandler
US176694A (en) *		1876-04-25		Improvement in screw-cutting die-stocks
JPS5825980B2 (ja) *	1976-02-12	1983-05-31	ヤマサ醤油株式会社	サイクリックヌクレオチドの定量法
JPS63258474A (ja)	1986-08-15	1988-10-25	セドナ・ファ−マセウチカルズ・ビ−・ブイ	カルバゾ−ル、ジベンゾフラン又はジベンゾチオフェン基を含む化合物の水酸基誘導体を調製するための方法
US5049655A (en) *	1989-03-22	1991-09-17	The Salk Institute For Biological Studies	Melanin-concentrating hormones
JP2906654B2 (ja)	1989-11-28	1999-06-21	東レ株式会社	免疫抑制剤及びその製造方法
US5401629A (en) *	1990-08-07	1995-03-28	The Salk Institute Biotechnology/Industrial Associates, Inc.	Assay methods and compositions useful for measuring the transduction of an intracellular signal
JP3160941B2 (ja)	1991-06-17	2001-04-25	東レ株式会社	カルバゾール誘導体および免疫抑制剤
EP0596897B1 (en) *	1991-07-05	2002-03-13	Smithkline Becham S.P.A.	Hydroisoquinoline derivatives
CA2124455C (en)	1992-09-29	2004-09-14	Hiroshi Nagase	Indole derivatives, process for producing the same and medicinal uses of the same
US5272146A (en) *	1992-10-02	1993-12-21	The United States Of America As Represented By The United States Department Of Health And Human Services	1,2-dihydroellipticines with activity against CNS specific cancer cell lines
US5457208A (en) *	1993-06-21	1995-10-10	Regents Of The University Of Minnesota	Kappa opioid receptor antagonists
US5464841A (en)	1993-11-08	1995-11-07	Univ Minnesota	Use of delta opioid receptor antagonists to treat immunoregulatory disorders
US5578725A (en)	1995-01-30	1996-11-26	Regents Of The University Of Minnesota	Delta opioid receptor antagonists
US5849708A (en) *	1995-06-06	1998-12-15	Joslin Diabetes Center, Inc.	Promotion of eating behavior
EP0848060A3 (en) *	1996-12-11	2000-02-02	Smithkline Beecham Corporation	Novel human 11CB splice variant
EP0894799B1 (en)	1997-01-16	2004-04-07	Toray Industries, Inc.	Indolomorphinane derivatives and remedies/preventives for cerebral disorders
US6555339B1 (en)	1997-04-14	2003-04-29	Arena Pharmaceuticals, Inc.	Non-endogenous, constitutively activated human protein-coupled receptors
JP2001525178A (ja)	1997-12-03	2001-12-11	スミスクラインビーチャムコーポレーション	ヒト１１ｃｂスプライス変異体に対するアゴニストおよびアンタゴニストの探索方法
JP2002517444A (ja)	1998-06-11	2002-06-18	メルクエンドカムパニーインコーポレーテッド	メラノコルチン受容体作動薬としてのスピロピペリジン誘導体
CA2342833A1 (en)	1998-09-17	2000-03-23	Incyte Pharmaceuticals, Inc.	Human gpcr proteins
GB9822158D0 (en)	1998-10-09	1998-12-02	Nycomed Imaging As	Compositions
CN1344321A (zh)	1998-12-28	2002-04-10	武田药品工业株式会社	筛选方法
US6221613B1 (en)	1998-12-31	2001-04-24	Synaptic Pharmaceutical Corporation	DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
WO2000049170A1 (en)	1999-02-18	2000-08-24	Smithkline Beecham Corporation	MURINE 11cby RECEPTOR
EP1153932A1 (en)	1999-02-19	2001-11-14	Takeda Chemical Industries, Ltd.	Novel g protein-coupled receptor protein and dna thereof
EP1183539A1 (en)	1999-05-19	2002-03-06	AstraZeneca AB	Assays for agonists, agonists and inverse agonists of melanin concentrating hormone (mch) binding to the somatostatin-like receptor (slc-1)
AU5869100A (en)	1999-06-08	2000-12-28	Regents Of The University Of California, The	Melanin concentrating hormone receptor
CA2378917A1 (en)	1999-07-14	2001-01-25	Merck & Co., Inc.	Melanin-concentrating hormone receptor
WO2001007611A2 (en)	1999-07-26	2001-02-01	Genentech, Inc.	Novel polynucleotides and method for the use thereof
WO2001007606A1 (en)	1999-07-27	2001-02-01	Smithkline Beecham Plc	Axor21, a g-protein coupled receptor
AU7315800A (en)	1999-09-20	2001-04-24	Takeda Chemical Industries Ltd.	Mch antagonists
WO2001021577A2 (en)	1999-09-20	2001-03-29	Takeda Chemical Industries, Ltd.	Melanin concentrating hormone antagonist
US6593108B1 (en)	1999-11-16	2003-07-15	Merck & Co., Inc.	Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide
JP2001226269A (ja)	2000-02-18	2001-08-21	Takeda Chem Ind Ltd	メラニン凝集ホルモン拮抗剤
JP2003532388A (ja)	2000-03-15	2003-11-05	メルクエンドカムパニーインコーポレーテッド	メラニン凝集ホルモン受容体キメラおよび融合タンパク質
JP2005229804A (ja)	2000-03-24	2005-09-02	Astellas Pharma Inc	新規なメラニンコンセントレーティングホルモン受容体
AU2001256733A1 (en)	2000-05-16	2001-11-26	Takeda Chemical Industries Ltd.	Melanin-concentrating hormone antagonist
CA2384358A1 (en)	2000-07-05	2002-01-10	Synaptic Pharmaceutical Corporation	Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
DE60143525D1 (de)	2000-07-05	2011-01-05	Takeda Pharmaceutical	Verfahren zum screenen von mhc-rezeptorantagonisten oder -agonisten
WO2002006245A1 (en)	2000-07-05	2002-01-24	Synaptic Pharmarceutical Corporation	Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
AU2001279294A1 (en) *	2000-07-06	2002-01-21	Neurogen Corporation	Melanin concentrating hormone receptor ligands
SK4612003A3 (en)	2000-10-20	2004-06-08	Pfizer Prod Inc	Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
US20030022891A1 (en)	2000-12-01	2003-01-30	Anandan Palani	MCH antagonists and their use in the treatment of obesity
HK1054390B (en) *	2000-12-22	2006-01-06	Schering Corporation	Piperidine mch antagonists and their use in the treatment of obesity
US6900329B2 (en)	2001-03-21	2005-05-31	Schering Corporation	MCH antagonists and their use in the treatment of obesity
IL157456A0 (en)	2001-03-21	2004-03-28	Pharmacopeia Inc Pharmacopeia	Aryl and biaryl compounds having mch modulatory activity
ATE460163T1 (de) *	2001-04-12	2010-03-15	Pharmacopeia Llc	Arly und diaryl piperidinderivate verwendbar als mch-hemmer
US6809104B2 (en)	2001-05-04	2004-10-26	Tularik Inc.	Fused heterocyclic compounds
US6858619B2 (en) *	2001-05-04	2005-02-22	Amgen Inc.	Fused heterocyclic compounds
BR0209932A (pt)	2001-05-22	2004-10-13	Neurogen Corp	Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
US6664273B2 (en) *	2001-11-26	2003-12-16	Schering Corporation	Piperidine based MCH antagonists for treatment of obesity and CNS disorders
JP2005532991A (ja) *	2002-01-10	2005-11-04	ニューロジェン・コーポレーション	メラニン凝集ホルモン受容体リガンド：置換２−（４−ベンジル−ピペラジン−１−イルメチル）−及び２−（４−ベンジル−ジアゼパン−１−イルメチル）−１ｈ−ベンゾイミダゾールアナログ
PL376659A1 (pl) *	2002-11-06	2006-01-09	Tularik Inc.	Skondensowane związki heterocykliczne

2003
- 2003-11-06 PL PL376659A patent/PL376659A1/pl not_active Application Discontinuation
- 2003-11-06 AU AU2003285160A patent/AU2003285160B2/en not_active Ceased
- 2003-11-06 EP EP03779483A patent/EP1562943A1/en not_active Withdrawn
- 2003-11-06 JP JP2004551872A patent/JP4547266B2/ja not_active Expired - Fee Related
- 2003-11-06 ZA ZA200503654A patent/ZA200503654B/en unknown
- 2003-11-06 BR BR0316070-0A patent/BR0316070A/pt not_active IP Right Cessation
- 2003-11-06 CN CNA2007101119484A patent/CN101134757A/zh active Pending
- 2003-11-06 US US10/705,173 patent/US7253179B2/en not_active Expired - Fee Related
- 2003-11-06 MX MXPA05004739A patent/MXPA05004739A/es active IP Right Grant
- 2003-11-06 EA EA200500770A patent/EA009421B1/ru not_active IP Right Cessation
- 2003-11-06 WO PCT/US2003/035543 patent/WO2004043958A1/en not_active Ceased
- 2003-11-06 NZ NZ540328A patent/NZ540328A/en unknown
- 2003-11-06 CN CNB2003801082225A patent/CN1330651C/zh not_active Expired - Fee Related
- 2003-11-06 KR KR1020057008174A patent/KR20050103184A/ko not_active Withdrawn
- 2003-11-06 CA CA002505372A patent/CA2505372A1/en not_active Abandoned
2005
- 2005-05-02 IS IS7833A patent/IS7833A/is unknown
- 2005-06-02 NO NO20052655A patent/NO20052655L/no not_active Application Discontinuation
2007
- 2007-07-26 US US11/881,805 patent/US20080058365A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN101134757A (zh)	2008-03-05
AU2003285160A1 (en)	2004-06-03
EA009421B1 (ru)	2007-12-28
US20040147538A1 (en)	2004-07-29
CA2505372A1 (en)	2004-05-27
EA200500770A1 (ru)	2005-12-29
AU2003285160B2 (en)	2009-06-04
JP4547266B2 (ja)	2010-09-22
IS7833A (is)	2005-05-02
EP1562943A1 (en)	2005-08-17
JP2006508130A (ja)	2006-03-09
CN1330651C (zh)	2007-08-08
ZA200503654B (en)	2006-09-27
US7253179B2 (en)	2007-08-07
NO20052655D0 (no)	2005-06-02
KR20050103184A (ko)	2005-10-27
NZ540328A (en)	2008-02-29
MXPA05004739A (es)	2005-08-02
US20080058365A1 (en)	2008-03-06
CN1735613A (zh)	2006-02-15
NO20052655L (no)	2005-07-26
WO2004043958A1 (en)	2004-05-27
BR0316070A (pt)	2005-09-27

Publication	Publication Date	Title
EP1687002A4 (en)	2008-07-23	CONDENSED HETEROCYCLIC COMPOUNDS
IL174283A0 (en)	2006-08-01	Fused heterocyclic compounds
PL377087A1 (pl)	2006-01-23	Związki heterocykliczne
PT2042504E (pt)	2011-09-07	Derivados da azolepirimidina fundida
AU2003291310A8 (en)	2004-06-03	Fused heterocyclic compounds and use thereof
PL374544A1 (pl)	2005-10-31	Związki imidazo-skondensowane
ZA200603881B (en)	2010-01-27	Substituted fused heterocyclic C-glycosides
IL175489A0 (en)	2009-02-11	Substituted fused heterocyclic c-glycosides
IL165178A0 (en)	2005-12-18	Novel fused imidazole derivative
IL179414A0 (en)	2007-05-15	Fused heterocyclic compound
IL177933A0 (en)	2006-12-31	New compounds
IL166650A0 (en)	2006-01-15	New compounds
AU2003264018A8 (en)	2004-02-25	New compounds
IL163894A0 (en)	2005-12-18	New compounds
GB0315870D0 (en)	2003-08-13	Heterocyclic derivatives
PL378249A1 (pl)	2006-03-20	Skondensowane pochodne furanu
MY143373A (en)	2011-04-29	Novel fused pyrrolocarbazoles
MY142713A (en)	2010-12-31	Novel fused pyrrolocarbazoles
EP1476425A4 (en)	2010-05-05	Heterocyclic Aryl Sulphonamidocyclic Compounds
EP1737446A4 (en)	2010-05-26	CONDENSED HETEROCYCLIC COMPOUNDS
GB0120818D0 (en)	2001-10-17	Heterocyclic compounds
HU0203976D0 (en)	2003-01-28	New compounds
PL376659A1 (pl)	2006-01-09	Skondensowane związki heterocykliczne
AU2003280578A1 (en)	2004-05-25	Heterocyclic compounds
GB0226609D0 (en)	2002-12-24	Heterocyclic derivatives

Legal Events

Date	Code	Title	Description
2011-02-28	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)